blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2348049

EP2348049 - APPLICATION OF AIMP1 POLYPEPTIDE [Right-click to bookmark this link]
Former [2011/30]NOVEL APPLICATION OF AIMP1 POLYPEPTIDE
[2013/15]
StatusNo opposition filed within time limit
Status updated on  08.08.2014
Database last updated on 02.07.2024
Most recent event   Tooltip10.06.2016Change - lapse in a contracting state
Updated state(s): GR		published on 13.07.2016  [2016/28]
Applicant(s)For all designated states
Medicinal Bioconvergence Research Center
8th Fl. B-dong
Advanced Institutes of Convergence Technology
864-1, lui-dong, Yeongtong-gu
Suwon-si, Gyeonggi-do 443-270 / KR
[2014/13]
Former [2011/30]For all designated states
SNU R&DB Foundation
San 56-1, Sillim-dong Gwanak-gu
Seoul 151-742 / KR
Inventor(s)01 / KIM, Sunghoon
1709 Tower Palace F-dong
Dogok 2-dong
Gangnam-gu
Seoul 135-536 / KR
02 / HAN, Jung Min
138-601 Gwanakdreamtown Apt.
Bongcheon 5-dong
Gwanak-gu
Seoul 151-774 / KR
 [2013/40]
Former [2011/30]01 / KIM, Sunghoon
1709 Tower Palace F-dong Dogok 2-dong Gangnam-gu
Seoul 135-536 / KR
02 / HAN, Jung Min
138-601 Gwanakdreamtown Apt. Bongcheon 5-dong Gwanak-gu
Seoul 151-774 / KR
Representative(s)Gulde & Partner
Patent- und Rechtsanwaltskanzlei mbB
Wallstrasse 58/59
10179 Berlin / DE
[N/P]
Former [2013/40]Gulde Hengelhaupt Ziebig & Schneider
Patentanwälte - Rechtsanwälte Wallstrasse 58/59
10179 Berlin / DE
Former [2011/30]Gulde Hengelhaupt Ziebig & Schneider
Patentanwälte - Rechtsanwälte Wallstrasse 58/59
10179 Berlin / DE
Application number, filing date09819399.809.10.2009
[2011/30]
WO2009KR05778
Priority number, dateKR2008009978210.10.2008         Original published format: KR 20080099782
[2011/30]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2010041892
Date:15.04.2010
Language:KO
[2010/15]
Type: A2 Application without search report 
No.:EP2348049
Date:27.07.2011
Language:EN
[2011/30]
Type: B1 Patent specification 
No.:EP2348049
Date:02.10.2013
Language:EN
[2013/40]
Search report(s)International search report - published on:KR19.08.2010
(Supplementary) European search report - dispatched on:EP27.02.2012
ClassificationIPC:G01N33/564
[2013/15]
CPC:
G01N33/564 (EP,KR,US); G01N2800/102 (EP,KR,US)
Former IPC [2012/13]C07K16/18, G01N33/564
Former IPC [2011/30]C07K16/18
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2011/30]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:ANWENDUNG DES AIMP1-POLYPEPTIDS[2013/15]
English:APPLICATION OF AIMP1 POLYPEPTIDE[2013/15]
French:UTILISATION DU POLYPEPTIDE AIMP1[2013/15]
Former [2011/30]NEUE ANWENDUNG DES AIMP1-POLYPEPTIDS
Former [2011/30]NOVEL APPLICATION OF AIMP1 POLYPEPTIDE
Former [2011/30]NOUVELLE UTILISATION DU POLYPEPTIDE AIMP1
Entry into regional phase05.05.2011Translation filed 
05.05.2011National basic fee paid 
05.05.2011Search fee paid 
05.05.2011Designation fee(s) paid 
05.05.2011Examination fee paid 
Examination procedure05.05.2011Examination requested  [2011/30]
17.09.2012Amendment by applicant (claims and/or description)
16.10.2012Despatch of a communication from the examining division (Time limit: M04)
18.02.2013Reply to a communication from the examining division
26.04.2013Communication of intention to grant the patent
23.08.2013Fee for grant paid
23.08.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.10.2012
Opposition(s)03.07.2014No opposition filed within time limit [2014/37]
Fees paidRenewal fee
27.10.2011Renewal fee patent year 03
30.10.2012Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU09.10.2009
AT02.10.2013
BE02.10.2013
BG02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
MT02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
LU09.10.2013
NO01.01.2014
GR03.01.2014
IS02.02.2014
PT03.02.2014
[2016/28]
Former [2016/21]HU09.10.2009
AT02.10.2013
BE02.10.2013
BG02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
GR02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
MT02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
LU09.10.2013
NO01.01.2014
IS02.02.2014
PT03.02.2014
Former [2015/41]HU09.10.2009
AT02.10.2013
BE02.10.2013
BG02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
GR02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
MT02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
LU09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2015/38]HU09.10.2009
AT02.10.2013
BE02.10.2013
BG02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
GR02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
LU09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2015/34]HU09.10.2009
AT02.10.2013
BE02.10.2013
BG02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
LU09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2015/32]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
MK02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
TR02.10.2013
IE09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2015/24]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
SM02.10.2013
IE09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/48]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
IE09.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/41]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
DK02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/38]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
IT02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/37]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
RO02.10.2013
SE02.10.2013
SI02.10.2013
SK02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/36]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
EE02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/33]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
MC02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/28]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
PT03.02.2014
Former [2014/26]AT02.10.2013
BE02.10.2013
CY02.10.2013
CZ02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
Former [2014/25]AT02.10.2013
BE02.10.2013
CZ02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
LV02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
Former [2014/24]AT02.10.2013
BE02.10.2013
CZ02.10.2013
ES02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
NL02.10.2013
PL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
Former [2014/23]BE02.10.2013
CZ02.10.2013
FI02.10.2013
HR02.10.2013
LT02.10.2013
NL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
IS02.02.2014
Former [2014/22]FI02.10.2013
LT02.10.2013
NL02.10.2013
SE02.10.2013
SI02.10.2013
NO02.01.2014
Former [2014/20]LT02.10.2013
SI02.10.2013
NO02.01.2014
Former [2014/12]SI02.10.2013
Documents cited:Search[Y]WO2007100058  (UNIV CHIBA NAT UNIV CORP [JP], et al) [Y] 5,6,8 * abstract *;
 EP2006681  [ ] (UNIV CHIBA NAT UNIV CORP [JP]) [ ] * claims 1-7 *;
 [X]US6228837  (STERN DAVID M [US], et al) [X] 1-4,7 * columns 2,10; claim 1; sequence 36 *;
 [X]WO2008007818  (SEOUL NAT UNIV IND FOUNDATION [KR], et al) [X] 1-4,7 * pages 9,15; figures 1-7,15; example 1; claims 1,12; sequence 1 *;
 [XP]WO2008133359  (IMAGENE CO LTD [KR], et al) [XP] 1-8 * pages 8,39; claims 11,12 *
 [Y]  - GU J ET AL, "CLUES TO PATHOGENESIS OF SPONDYLOARTHROPATHY DERIVED FROM SYNOVIAL FLUID MONONUCLEAR CELL GENE EXPRESSION PROFILES", JOURNAL OF RHEUMATOLOGY, JOURNAL OF RHEUMATOLOGY PUBLISHING COMPANY, CA, (20021001), vol. 29, no. 10, ISSN 0315-162X, pages 2159 - 2164, XP008029647 [Y] 5,6,8 * abstract *
 [X]  - ARIANNA BOTTONI ET AL, "Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines", JOURNAL OF CELLULAR PHYSIOLOGY, (20070801), vol. 212, no. 2, doi:10.1002/jcp.21083, ISSN 0021-9541, pages 293 - 297, XP055019487 [X] 1-4,7 * abstract * * page 294 *

DOI:   http://dx.doi.org/10.1002/jcp.21083
    [ ] - "AIMP1_HUMAN", UniProt, (20060124), Database accession no. Q12904, XP002669672
International search[A]WO0195927  (IMAGENE CO LTD [KR], et al);
 [A]EP1384486  (SEOUL NAT UNIV IND FOUNDATION [KR])
 [X]  - KO, Y. G. ET AL., "A cofactor oftRNA synthetase, p43, is secreted to up-regulated proinflammatory genes.", JOURNAL OF BIOLOGICAL CHEMISTRY, (20010405), vol. 276, no. 25, pages 23028 - 23033, XP008120067

DOI:   http://dx.doi.org/10.1074/jbc.m101544200
 [A]  - HAN, J. M. ET AL., "Aminoacyl-tRNA synthetase-interacting multifunctional protein 1/p43 controls endoplasmic reticulum retention of heat shock protein gp96:its pathological implications in lupus-like autoimmune disease.", AMERICAN JOURNAL OF PATHOLOGY., (200706), vol. 170, no. 6, pages 2042 - 2054, XP008136864

DOI:   http://dx.doi.org/10.2353/ajpath.2007.061266
 [A]  - KIM, E. ET AL., "AIMP1/p43 protein induces the maturation of bone marrow-derived dendritic cells with T-helper type 1-polarizing ability.", JOURNAL OF IMMUNOLOGY, (20080301), vol. 180, no. 5, pages 2894 - 2902, XP008136870
 [A]  - KIM. T. S. ET AL., "Gene transfer of AIMP1 and B7. 1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.", VACCINE., (20080913), vol. 26, no. 47, pages 5928 - 5934, XP025613276

DOI:   http://dx.doi.org/10.1016/j.vaccine.2008.08.051
by applicant   - SANG GYU PARK ET AL., TRENDS IN BIOCHEMICAL SCIENCES, (2005), vol. 30, pages 569 - 574
    - DEUTSCHER, M. P., METHOD ENZYMOL, (1974), vol. 29, pages 577 - 583
    - DANG C. V. ET AL., INT. J. BIOCHEM., (1982), vol. 14, pages 539 - 543
    - MIRANDE, M. ET AL., EMBO J., (1982), vol. 1, pages 733 - 736
    - YANG D. C. ET AL., CURR. TOP. CELL. REGUL., (1985), vol. 26, pages 325 - 335
    - PARK S. G. ET AL., J. BIOL. CHEM., (1999), vol. 274, pages 16673 - 16676
    - PARK S. G. ET AL., AM. J. PATHOL., (2005), vol. 166, pages 387 - 398
    - BARNETT G. ET AL., CANCER RES., (2000), vol. 60, pages 2850 - 2857
    - DAYHOFF ET AL., ATLAS OF PROTEIN SEQUENCE AND STRUCTURE, (1978), vol. 5, no. 3
    - KOHLER, MILSTEIN, EUROPEAN JOURNAL OF IMMUNOLOGY, (1976), vol. 6, pages 511 - 519
    - CLACKSON ET AL., NATURE, (1991), vol. 352, pages 624 - 628
    - MARKS ET AL., J. MOL. BIOL., (1991), vol. 222, no. 58, pages 1 - 597
    - HITZEMAN ET AL., J. BIOL. CHEM., (1990), vol. 255, pages 12073 - 12080
    - CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, (2007), vol. 44, pages 339 - 363
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.